Browsing by Author Puzanov, Igor

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2012Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trialKefford, Richard (Rick); Long, Georgina; Algazi, Alain; Ascierto, Paolo; Chapman, Paul; Davies, Michael; et al, Various; Hauschild, A; Mortier, Laurent; Puzanov, Igor; Robert, C; Tawbi, Hussein; Trefzer, Uwe; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer CentreDabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial, The Lancet Oncology, vol.13, 11, 2012,pp 1087-1095
2016Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune DisordersCarlino, Matteo; Guminski, Alexander; Long, Georgina; Menzies, Alexander Maxwel; Buchbinder, Elizabeth I; et al, Various; Johnson, Douglas B; Khushalani, Nikhil I; Lawrence, Donald; Mudigonda, Tejaswi; Ott, Patrick A; Puzanov, Igor; Sullivan, Ryan; Ye, Fei; Western Clinical School: Medicine (Westmead); Medicine Faculty Office; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: MedicineIpilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders, JAMA Oncology, vol.2, 2, 2016,pp 234-240
2015Multiple gastrointestinal polyps in patients treated with BRAF inhibitorsCarlino, Matteo; Long, Georgina; Amaravadi, Ravi; Del Portillo, Armando; et al, Various; Hamilton, Kathryn E; Ma, Xiaohong; Morrissette, Jennifer J D; Nathanson, Katherine L.; Piao, Shengfu; Puzanov, Igor; Tsai, Kenneth Y; Xu, X; Western Clinical School: Medicine (Westmead); Central Clinical School: The Sydney Cancer CentreMultiple gastrointestinal polyps in patients treated with BRAF inhibitors, Clinical Cancer Research, vol.21, 23, 2015,pp 5215-5221
2017Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 ImmunotherapyLong, Georgina; Andtbacka, R; Cebon, Jonathan Simon; Dummer, R; et al, Various; Malvehy, Josep; Michielin, Olivier; Olszanski, Anthony; Puzanov, Igor; Ribas, Antoni; VanderWalde, Ari; Northern Clinical School: MedicineOncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy, Cell, vol.170, 6, 2017,pp 1109-1119